Abang, Rashfek D.
HRN: 21-79-00 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/29/2022
12/05/2022
IV
150mg
Q8Hrs
AGE With Mod Dehydration; Covid-19 Pneumonia Mild
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: PneumoniaIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes